205 related articles for article (PubMed ID: 32416700)
1. Benzophenone Sulfonamide Derivatives as Interacting Partners and Inhibitors of Human P-glycoprotein.
Farman S; Javed A; Arshia ; Khan KM; Nasir A; Khan AU; Lodhi MA; Gul H; Khan F; Asad M; Parveen Z
Anticancer Agents Med Chem; 2020; 20(14):1739-1751. PubMed ID: 32416700
[TBL] [Abstract][Full Text] [Related]
2. Homology Modeling of the Human P-glycoprotein (ABCB1) and Insights into Ligand Binding through Molecular Docking Studies.
Mora Lagares L; Minovski N; Caballero Alfonso AY; Benfenati E; Wellens S; Culot M; Gosselet F; Novič M
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32517082
[TBL] [Abstract][Full Text] [Related]
3. Modulation of P-glycoprotein activity by novel synthetic curcumin derivatives in sensitive and multidrug-resistant T-cell acute lymphoblastic leukemia cell lines.
Ooko E; Alsalim T; Saeed B; Saeed MEM; Kadioglu O; Abbo HS; Titinchi SJJ; Efferth T
Toxicol Appl Pharmacol; 2016 Aug; 305():216-233. PubMed ID: 27318188
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships, ligand efficiency, and lipophilic efficiency profiles of benzophenone-type inhibitors of the multidrug transporter P-glycoprotein.
Jabeen I; Pleban K; Rinner U; Chiba P; Ecker GF
J Med Chem; 2012 Apr; 55(7):3261-73. PubMed ID: 22452412
[TBL] [Abstract][Full Text] [Related]
5. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function.
Teng YN; Sheu MJ; Hsieh YW; Wang RY; Chiang YC; Hung CC
Phytomedicine; 2016 Mar; 23(3):316-23. PubMed ID: 26969385
[TBL] [Abstract][Full Text] [Related]
6. Reversal effect of FW-04-806, a macrolide dilactone compound, on multidrug resistance mediated by ABCB1 and ABCG2 in vitro and in vivo.
Zhang Z; Ma C; Li P; Wu M; Ye S; Fu L; Xu J
Cell Commun Signal; 2019 Sep; 17(1):110. PubMed ID: 31472682
[TBL] [Abstract][Full Text] [Related]
7. Discovery of new pyrimidopyrrolizine/indolizine-based derivatives as P-glycoprotein inhibitors: Design, synthesis, cytotoxicity, and MDR reversal activities.
Shawky AM; Abdalla AN; Ibrahim NA; Abourehab MAS; Gouda AM
Eur J Med Chem; 2021 Jun; 218():113403. PubMed ID: 33823396
[TBL] [Abstract][Full Text] [Related]
8. Design, green synthesis, molecular docking and anticancer evaluations of diazepam bearing sulfonamide moieties as VEGFR-2 inhibitors.
Saleh NM; El-Gaby MSA; El-Adl K; Abd El-Sattar NEA
Bioorg Chem; 2020 Nov; 104():104350. PubMed ID: 33142416
[TBL] [Abstract][Full Text] [Related]
9. Modulation of the spacer in N,N-bis(alkanol)amine aryl ester heterodimers led to the discovery of a series of highly potent P-glycoprotein-based multidrug resistance (MDR) modulators.
Dei S; Braconi L; Trezza A; Menicatti M; Contino M; Coronnello M; Chiaramonte N; Manetti D; Perrone MG; Romanelli MN; Udomtanakunchai C; Colabufo NA; Bartolucci G; Spiga O; Salerno M; Teodori E
Eur J Med Chem; 2019 Jun; 172():71-94. PubMed ID: 30947123
[TBL] [Abstract][Full Text] [Related]
10. Isopetasin and S-isopetasin as novel P-glycoprotein inhibitors against multidrug-resistant cancer cells.
Abdelfatah S; Böckers M; Asensio M; Kadioglu O; Klinger A; Fleischer E; Efferth T
Phytomedicine; 2021 Jun; 86():153196. PubMed ID: 32229058
[TBL] [Abstract][Full Text] [Related]
11. Screening dietary flavonoids for the reversal of P-glycoprotein-mediated multidrug resistance in cancer.
Mohana S; Ganesan M; Agilan B; Karthikeyan R; Srithar G; Beaulah Mary R; Ananthakrishnan D; Velmurugan D; Rajendra Prasad N; Ambudkar SV
Mol Biosyst; 2016 Jul; 12(8):2458-70. PubMed ID: 27216424
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and bioactivity study on 5-phenylfuran derivatives as potent reversal agents against P-glycoprotein-mediated multidrug resistance in MCF-7/ADR cell.
Li YS; Yang X; Zhao DS; Cai Y; Huang Z; Wu R; Wang SJ; Liu GJ; Wang J; Bao XZ; Ye XY; Wei B; Cui ZN; Wang H
Eur J Med Chem; 2021 Apr; 216():113336. PubMed ID: 33725657
[TBL] [Abstract][Full Text] [Related]
13. Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes.
To KKW; Wu X; Yin C; Chai S; Yao S; Kadioglu O; Efferth T; Ye Y; Lin G
J Ethnopharmacol; 2017 May; 203():110-119. PubMed ID: 28363522
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, in silico and in vitro studies of new 1,4-dihydropiridine derivatives for antitumor and P-glycoprotein inhibitory activity.
Mollazadeh S; Sahebkar A; Kalalinia F; Behravan J; Hadizadeh F
Bioorg Chem; 2019 Oct; 91():103156. PubMed ID: 31416030
[TBL] [Abstract][Full Text] [Related]
15. Novel Heat Shock Protein 90 Inhibitors Suppress P-Glycoprotein Activity and Overcome Multidrug Resistance in Cancer Cells.
Dinić J; Podolski-Renić A; Jovanović M; Musso L; Tsakovska I; Pajeva I; Dallavalle S; Pešić M
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31527404
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and anticancer evaluation of benzophenone derivatives bearing naphthalene moiety as novel tubulin polymerization inhibitors.
Wang G; Liu W; Tang J; Ma X; Gong Z; Huang Y; Li Y; Peng Z
Bioorg Chem; 2020 Nov; 104():104265. PubMed ID: 32919128
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of thiophenylbenzofuran derivatives as potential P-glycoprotein inhibitors.
Hung CC; Chen CY; Wu YC; Huang CF; Huang YC; Chen YC; Chang CS
Eur J Med Chem; 2020 Sep; 201():112422. PubMed ID: 32569926
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of N-(4-(2-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)phenyl)-4-oxo-3,4-dihydrophthalazine-1-carboxamide derivatives as novel P-glycoprotein inhibitors reversing multidrug resistance.
Qiu Q; Zhou J; Shi W; Kairuki M; Huang W; Qian H
Bioorg Chem; 2019 May; 86():166-175. PubMed ID: 30710850
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, biological evaluation and 3D-QSAR studies of new chalcone derivatives as inhibitors of human P-glycoprotein.
Parveen Z; Brunhofer G; Jabeen I; Erker T; Chiba P; Ecker GF
Bioorg Med Chem; 2014 Apr; 22(7):2311-9. PubMed ID: 24613626
[TBL] [Abstract][Full Text] [Related]
20. Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors.
Dallavalle S; Dobričić V; Lazzarato L; Gazzano E; Machuqueiro M; Pajeva I; Tsakovska I; Zidar N; Fruttero R
Drug Resist Updat; 2020 May; 50():100682. PubMed ID: 32087558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
